| Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft … D Callegaro, R Miceli, S Bonvalot, P Ferguson, DC Strauss, A Levy, ... The Lancet Oncology 17 (5), 671-680, 2016 | 382 | 2016 |
| Definition of synchronous oligometastatic non–small cell lung cancer—a consensus report AMC Dingemans, LEL Hendriks, T Berghmans, A Levy, B Hasan, ... Journal of Thoracic Oncology 14 (12), 2109-2119, 2019 | 229 | 2019 |
| Radiation-enhanced cell migration/invasion process: A review C Moncharmont, A Levy, JB Guy, AT Falk, M Guilbert, JC Trone, ... Critical reviews in oncology/hematology 92 (2), 133-142, 2014 | 193 | 2014 |
| Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials C Ferté, M Fernandez, A Hollebecque, S Koscielny, A Levy, C Massard, ... Clinical Cancer Research 20 (1), 246-252, 2014 | 179 | 2014 |
| Targeting a cornerstone of radiation resistance: cancer stem cell C Moncharmont, A Levy, M Gilormini, G Bertrand, C Chargari, G Alphonse, ... Cancer letters 322 (2), 139-147, 2012 | 170 | 2012 |
| Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities S Postel-Vinay, C Gomez-Roca, LR Molife, B Anghan, A Levy, I Judson, ... J Clin Oncol 29 (13), 1728-1735, 2011 | 145 | 2011 |
| Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC) C Lebbe, C Garbe, AJ Stratigos, C Harwood, K Peris, V del Marmol, ... European Journal of Cancer 114, 117-127, 2019 | 144 | 2019 |
| Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives H Mirghani, F Amen, Y Tao, E Deutsch, A Levy Cancer treatment reviews 41 (10), 844-852, 2015 | 143 | 2015 |
| Radiotherapy–immunotherapy combinations–perspectives and challenges M Mondini, A Levy, L Meziani, F Milliat, E Deutsch Molecular oncology 14 (7), 1529-1537, 2020 | 130 | 2020 |
| Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial A Levy, C Massard, JC Soria, E Deutsch European Journal of Cancer 68, 156-162, 2016 | 124 | 2016 |
| Can immunostimulatory agents enhance the abscopal effect of radiotherapy? A Levy, C Chargari, A Marabelle, JL Perfettini, N Magné, E Deutsch European Journal of Cancer 62, 36-45, 2016 | 122 | 2016 |
| Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation G Bertrand, M Maalouf, A Boivin, P Battiston-Montagne, M Beuve, A Levy, ... Stem Cell Reviews and Reports 10 (1), 114-126, 2014 | 112 | 2014 |
| Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer: In … A Levy, M Guckenberger, C Hurkmans, U Nestle, J Belderbos, ... | 112* | |
| Interest of diffusion‐weighted echo‐planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: A review A Levy, A Medjhoul, C Caramella, E Zareski, O Berges, C Chargari, ... Journal of Magnetic Resonance Imaging 33 (5), 1020-1027, 2011 | 110 | 2011 |
| Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy … D Ou, P Blanchard, S Rosellini, A Levy, F Nguyen, RTH Leijenaar, ... Oral oncology 71, 150-155, 2017 | 104 | 2017 |
| Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial E Deutsch, C Lemanski, JP Pignon, A Levy, A Delarochefordiere, ... Annals of oncology 24 (11), 2834-2838, 2013 | 93 | 2013 |
| Radiation therapy and immunotherapy: implications for a combined cancer treatment A Levy, C Chargari, M Cheminant, N Simon, C Bourgier, E Deutsch Critical reviews in oncology/hematology 85 (3), 278-287, 2013 | 85 | 2013 |
| Primary extremity soft tissue sarcomas: does local control impact survival? S Bonvalot, A Levy, P Terrier, D Tzanis, S Bellefqih, A Le Cesne, ... Annals of surgical oncology 24, 194-201, 2017 | 82 | 2017 |
| Innate immune receptor NOD2 mediates LGR5+ intestinal stem cell protection against ROS cytotoxicity via mitophagy stimulation A Levy, A Stedman, E Deutsch, F Donnadieu, HW Virgin, PJ Sansonetti, ... Proceedings of the National Academy of Sciences, 2020 | 80 | 2020 |
| Risk factors for burnout among caregivers working in nursing homes N Kandelman, T Mazars, A Levy Journal of clinical nursing 27 (1-2), e147-e153, 2018 | 80 | 2018 |
Chargari CyrusProfessor of Radiation Oncology, Pitié Salpêtrière University HospitalE-mail megerősítve itt: aphp.fr
